69.2 F
New York
Wednesday, May 18, 2022

Aesthetic Medical [NASDAQ: AIH] Cancels Its Acquisition Contract Of Equity Interest In Hanfei

Must read

Aesthetic Medical International [NASDAQ: AIH] reported that the company has ceased its contract with Hanfei Investment management. The contract was to purchase a 51% equity interest in Hanfei. The acquisition agreement fell through because Hanfei could not meet its decided performance target because of the impact of Covid-19.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Chairman and CEO of Aesthetic Medical, Dr. Zhou Pengwu said “ We regret that due to the impact of Covid 19 the current market condition is not right for the acquisition of Hanfei. Furthermore, We determined that termination of this acquisition was in the best interest of the company and its shareholders. The company’s strategy is unwavering and we will continue to effectively execute our acquisition strategy”.

He further continued “In the future, we will proceed to explore and seek exciting opportunities in strategic investment and acquisition to address the developing demand and interest for aesthetic medical services globally.”

More articles

Latest article